Zusammenfassung
Das Ziel der Knochenmarktransplantation (KMT) ist der Ersatz blutbildenden Gewebes bei Individuen mit gestörter Blutbildung, maligne entarteter Blutbildung und gestörtem Immunsystem. Ferner kann die KMT eine wirkungsvolle hochdosierte zytostatische Behandlung anderer maligner Erkrankungen ermöglichen, die ansonsten durch die Knochenmarktoxizität der Behandlung begrenzt ist. Grundsätzlich besteht die Möglichkeit, die Reaktion immunkompetenter Zellen des Transplantates gegen den Empfänger — Graft-versus-Host-Reaktion (GvHR) — zur Ausschaltung restlicher leukämischer Zellen auszunützen. Die erfolgreiche Transplantation hämopoetischen Gewebes erlaubt in der Regel die Transplantation anderer Organe desselben Spenders ohne erneute immunsup-pressive Behandlung.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literaturverzeichnis
Amman AJ, Wara DW, Salman S, Perkins H (1973) Thymus transplantation — permanent reconstitution of cellular immunity in a patient with sex-linked combined immunodeficiency. N Engl J Med 289:5
Bekkum DW van (1974) Strategy of clinical bone-marrow transplantations with emphasis on treatment of combined immune deficiency. Transplant Proc 6:373
Billingham R, Brent L, Medawar P (1953) Actively acquired tolerance of foreign cells. Nature 172:603
Bostin MM, Rimm AA (1977) 7th report from the international bone marrow registry. Severe combined immunodeficiency disease: Characterization of the disease and results of transplantation. Transplant Proc 9:169
Buckner CD (1979) For the Seattle Marrow Transplant Team. Allogeneic marrow transplantation for patients with acute leukemia. Transplant Proc 11:215
Buckner CD, Clift RA, Sanders JE, Williams B, Gray M, Storb R, Thomas ED (1978) AB0-incompatible marrow transplants. Transplantation 26:233
Buckner CD, Storb R, Dillingham LA, Thomas ED (1970) Low temperature preservation of monkey marrow in dimethyl sulfoxide. Cryobiology 7:136
Camitta BM, Thomas ED (1978) Severe aplastic anemia: a prospective study of the effect of androgens or transplantation on hematological recovery and survival. Clin Haematol 7:587
Dicke KA, Hooft JIM van, Bekkum DW van (1968) The selective elimination of immunologically competent cells from bone marrow and lymphatic cell mixtures. Transplantation 6:562
Dicke KA, Zander A, Spitzer G, Verma DS, Peters L, Vellekoop L, McCredie KB, Hester J (1979) Autologous bone marrow transplantation in relapsed adult acute leukemia. Lancet 1:514
Dietrich M (1974) Klinische Gnotobiotik in der Hämatologie. Blut 5:317–320
Eernisse JG, Brand A (1977) Postponement (or prevention?) of immunization against HLA-antigens by blood and platelet transfusions. Br J Haematol 35:674
Epstein RB, Storb R, Ragde H, Thomas ED (1968) Cytotoxic typing antisera for marrow grafting in littermate dogs. Transplantation 6:45
Floersheim GL (1973) Induction of unresponsiveness to skin and heart allografts in mice by a synergistic treatment with Procarbazine, Antilymphocyteserum and donor type cells. Transplantation 15:195
Grosse-Wilde H, Vriesendorp HM, Netzel B, Mempel W, Kolb HJ, Wank R, Thierfelder S, Albert ED (1975) Immunogenetics of seven LD alleles of the DL-A complex in mongrels, beagles and labradors. Transplant Proc 7: [Suppl 1] 159
Jacobson LO, Marks EK, Robson JJ, Gastan EO, Zirkle RE (1949) The effect of spleen protection on mortality following X-irradiation. J Lab Clin Med 34:1638
Kersey J, Levitt S, Ramsay N, Krivit W, Nesbit M, Coccia P, Tim T (1978) Absence of rejection of human allogeneic marrow grafts as a result of immunosuppression with total lymphoid irradiation (TLI) and Cyclophosphamide. Exp Hematol 6: [Suppl 3] 37
Kersey J, Roloff J, Hokeness S, Johnson FL, Nesbit M, Krivit W (1975) Retransplantation of human bone marrow. Transplantation 19:475
Kolb HJ, Bodenberger U, Rodt HV, Rieder I, Netzel B, Grosse-Wilde H, Scholz S, Thierfelder S (1980) Bone marrow transplantation in DLA-haploidentical canine litermates: Fractionated total body irradiation (FTBI) and in vitro treatment of the marrow graft with anti-T-cell globulin (ATCG). Haematol Bluttransfus 25:61.
Kolb HJ, Rieder I, Rodt H, Netzel B, Grosse-Wilde H, Scholz S, Schäffer E, Kolb H, Thierfelder S (1979b) Antilymphocytic antibodies and marrow transplantation: VI Graft-versus-host tolerance in DLA-incompatible dogs following in vitro treatment of bone marrow with absorbed antithymocyteglobulin. Transplantation 27:242
Kolb HJ, Rieder I, Grosse-Wilde H, Abb J, Albert E, Kolb H, Schäffer E, Thierfelder S (1976) Marrow grafts in LD-SD typed dogs treated with cyclophosphamide. Transplant Proc 8:555
Kolb HJ, Rieder I, Grosse-Wilde H, Bodenberger U, Scholz S, Kolb H, Schäfer E, Thierfelder S (1979 a) Graft-versus-host disease following marrow grafts from DLA-matched littermates. Transplant Proc 11:507
Lorenz E, Uphoff D, Shelton E, Ried E (1951) Modification of irradiation injury in mice and guinea pigs by bone marrow injection. J Natl Cancer Inst 12:197–201
Lynch RE, Williams DM, Reading JC, Cartwricht GE (1975) The Prognosis in aplastic Anemia. Blood 45:517
Meuwissen HJ, Gatti RA, Terasaki PI, Hong R, Good RA (1969) Treatment of lymphopenic hypogammaglobulinemia and bone marrow aplasia by transplantation of allogeneic marrow. N Engl J Med 281:691
Meuwissen HJ, Pollara B, Pickewing RJ (1975) Summary of a Workshop held in Albany, New York, October 1st, 1973. Combined immunodeficiency disease associated with adenosin deaminase deficiency. J Pediatr 86:169
Neiman PE, Thomas ED, Reeves WC, Ray CG, Sale G, Lerner KG, Buckner CD, Clift RA, Storb R, Weiden PL, Fefer A (1976) Opportunistic infection and interstitial pneumonia following marrow transplantation for aplastic anemia and hematologic malignancy. Transplant Proc 8:663
Pillow RP, Epstein RB, Buckner CD, Giblett ER, Thomas ED (1966) Treatment of bone marrow failure by isogeneic marrow infusion. N Engl J Med 275:94
Putten LM van (1965) Quantitative aspects of the storage of bone marrow cells for transplantation. Eur J Cancer 1:15
Rapaport FT, Watanabe K, Cannon FD, Mollen N, Blumenstock D, Ferrebee JW (1972) Histocompatibility studies in a closely bred colony of dogs. IV. Tolerance to bone marrow, kidney and skin allografts in DL-A identical radiation chimaeras. J Exp Med 136:1080
Rieder I, Kolb HJ, Schäffer E, Kolb H, Grosse-Wilde H, Scholz S, Thierfelder S (1978) Leukocyte transfusions for the modification of host-versus-graft reactions in dogs. In: Baum SJ, Ledney DG (eds) Experimental hematology today 1978. Springer, Berlin Heidelberg New York, p 101
Rodt HV, Thierfelder S, Eulitz M (1974) Antilymphocytic antibodies and marrow transplantation. III. Effect of heterologous anti-brain antibodies on acute secondary disease in mice. Eur J Immunol 4:25
Schaefer UW, Schmidt CG, Dicke KA, Bekkum DW van (1975) Konservierung von hämopoetischen Stammzellen. Z Krebsforsch 83:285
Scheel J v, Koib HJ, Duswald KH, Rieder I, Chaussy C, Grosse-Wilde H, Scholz S, Pielsticker K (1977) Kidney transplantation in dogs following treatment with cyclophosphamide and bone marrow grafting. Transplant Proc 9:261
Slavin S, Gottlieb M, Strober S, Hoppe RT, Kaplan HS, Grumet FC (1979 a) Transplantation of bone marrow in out bred dogs without graft-versus-host disease using total lymphoid irradiation (TLI). Transplantation 27:139
Slavin S, Zan-Bar I, Strober S (1979b) Generation of protein-specific and alloantigen-specific suppressor cells following total lymphoid irradiation in mice. Transplant Proc 11:891
Storb R (1979b) For the Seattle Marrow Transplant Team. Decrease in the graft rejection rate and improvement in survival after marrow transplantation for severe aplastic anemia. Transplant Proc 11:196
Storb R, Deeg JJ, Weiden PL, Graham TC, Atkinson RA, Slichter SJ, Thomas ED (1979 a) Marrow graft rejection in DLA-identical canine littermates: antigens involved are expressed on leukocytes and skin epithelial cells but probably not on platelets and red blood cells. Transplant Proc 11:504
Storb R, Epstein RB, Graham TC, Thomas ED (1970 b) Methotrexate regimens for control of graft-versus-host disease in dogs with allogeneic marrow grafts. Transplantation 9:240
Storb R, Epstein RB, Rudolph RH, Thomas ED (1970 a) The effect of prior transfusions on marrow grafts between histocompatible canine siblings. J Immunol 105:627
Storb R, Floersheim GL, Weiden PL, Graham TC, Kolb HJ, Lerner KG, Schroeder ML, Thomas ED (1974) Effect of prior blood transfusions on marrow grafts: Abrogation of sensitization by procarbazine and antithymocyte serum. J Immunol 112:1508
Storb R, Kolb HJ, Graham TC, Kolb H, Weiden PL, Thomas ED (1973b) Treatment of established graft-versus-host disease in dogs by antithymocyte serum or prednisone. Blood 42:601
Storb R, Prentice RL, Thomas ED (1977 a) Treatment of aplastic anemia by marrow transplantation from HLA-identical sibling. Prognostic factors associated with graft-versus-host disease and survival. J Clin Invest 59:625
Storb R, Prentice RL, Thomas ED (1977 b) Marrow transplantation for treatment of aplastic anemia. An analysis of factors associated with graft rejection. N Engl J Med 296:61
Storb R, Rudolph RH, Kolb HJ, Graham TC, Mickelson E, Erickson V, Lerner KG, Kolb H, Thomas ED (1973 a) Marrow grafts between DL-A matched canine littermates. Transplantation 15:92
Strober S, Slavin S, Fuks Z, Kaplan HS, Gottlieb M, Bieber C, Hoppe RT, Grunnet FC (1979) Transplantation tolerance after total lymphoid irradiation (TLI). Transplant Proc 11:1032
Thierfelder S (1975) Experimental bone marrow transplantation. Blut 30:1
Thomas ED, Storb R (1970) Technique for human marrow grafting. Blood 36:507
Thomas ED, Bryant J, Buckner CD, Clift RA, Fefer A, Johnson FL, Neiman PE, Ramberg RE, Storb R (1972) Leukemic transformation of engrafted human marrow cells in vivo. Lancet II:1310
Thomas ED, Storb R, Clift RA, Fefer A, Johnson FL, Neiman PE, Lerner KG, Glucksberg H, Buckner CD (1975) Bone Marrow Transplantation (Two Parts). N Engl J Med 292:832
Thomas ED, Storb R, Clift RA, Fefer A, Johnson FL, Neiman PE, Lerner KG, Glucksberg H, Buckner CD (1975) Bone Marrow Transplantation (Two Parts). N Engl J Med 292:895
Trentin JJ (1957) Induced tolerance and “homologous disease” in x-irradiated mice protected with homologous bone marrow. Proc Soc Exp Biol Med 96:139
Vriesendorp HM, Epstein RB, d’Amaro J, Westbroek DL, Rood JJ van (1972) Polymorphism of the DL-A system. Transplantation 14:2–9
Vriesendorp HM, Bijnen AB, Kessel ACM van, Obertop H, Westbrock DL (1978) Minor histocompatibility systems in dogs. In: Baum SJ, Ledney GD (eds) Experimental hematology today 1978. Springer, Berlin Heidelberg New York, p 109
Weiden PL, Doney K, Storb R, Thomas ED (1978) Anti-human thymocyte globulin (ATG) for prophylaxis and treatment of graft-versus-host disease in recipients of allogeneic marrow grafts. Transplant Proc 10:213
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Kolb, H.J., Thierfelder, S. (1981). Transplantation von Knochenmark. In: Albert, E., et al. Transplantationschirurgie. Allgemeine und spezielle Operationslehre, vol 3. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-67966-7_39
Download citation
DOI: https://doi.org/10.1007/978-3-642-67966-7_39
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-67967-4
Online ISBN: 978-3-642-67966-7
eBook Packages: Springer Book Archive